Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Free Report) CFO Christopher Sullivan sold 12,394 shares of the stock in a transaction on Wednesday, September 16th. The stock was sold at an average price of $16.33, for a total value of $202,394.02. Following the transaction, the chief financial officer directly owned 39,900 shares in the company, valued […]

Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) EVP Peter Heerma sold 102,190 shares of the firm’s stock in a transaction dated Tuesday, September 15th. The shares were sold at an average price of $62.26, for a total value of $6,362,349.40. Following the sale, the executive vice president directly owned 117,066 shares in the company, […]

Oruka Therapeutics, Inc. (NASDAQ:ORKA – Get Free Report) insider Joana Goncalves sold 7,947 shares of the firm’s stock in a transaction that occurred on Tuesday, September 15th. The stock was sold at an average price of $92.38, for a total transaction of $734,143.86. Following the transaction, the insider directly owned 31,771 shares of the company’s […]

Aquestive Therapeutics, Inc. (NASDAQ:AQST – Get Free Report) insider Sherry Korczynski sold 8,750 shares of the company’s stock in a transaction that occurred on Wednesday, September 9th. The stock was sold at an average price of $5.22, for a total transaction of $45,675.00. Following the completion of the transaction, the insider owned 235,689 shares in […]

Aquestive Therapeutics, Inc. (NASDAQ:AQST – Get Free Report) insider Sherry Korczynski sold 8,750 shares of the company’s stock in a transaction dated Wednesday, September 9th. The stock was sold at an average price of $5.22, for a total value of $45,675.00. Following the completion of the sale, the insider owned 235,689 shares in the company, […]

Aardvark Therapeutics, Inc. (NASDAQ:AARD – Get Free Report) insider Nelson Sun sold 14,754 shares of Aardvark Therapeutics stock in a transaction on Thursday, September 10th. The shares were sold at an average price of $5.00, for a total transaction of $73,770.00. Following the sale, the insider directly owned 97,475 shares of the company’s stock, valued […]

Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) insider Douglas Kerr sold 1,290 shares of the business’s stock in a transaction dated Tuesday, September 8th. The stock was sold at an average price of $18.88, for a total transaction of $24,355.20. Following the sale, the insider directly owned 162,564 shares in the company, valued at […]

Spyre Therapeutics, Inc. (NASDAQ:SYRE – Get Free Report) insider Heidy King-Jones sold 27,999 shares of the stock in a transaction that occurred on Tuesday, September 1st. The stock was sold at an average price of $87.31, for a total value of $2,444,592.69. Following the completion of the transaction, the insider directly owned 2,845 shares in […]